Karen L Rascati

Karen L Rascati,

Adjunct Full Instructional Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-6268
Business Email: krascati@ufl.edu

Teaching Profile

Courses Taught
2012-2024
PHA6283 Introduction to Pharmacoeconomics
2013
PHA6287 Pharmaceutical Health Economics
2021-2024
PHA6935 Selected Topics in Pharmacy

Publications

2022
Economic Burden of Chronic Comorbidities Among Community-Dwelling Older Adults With Dementia: A Propensity Score Matched National-Level Study.
Alzheimer disease and associated disorders. 36(3):244-252 [DOI] 10.1097/WAD.0000000000000504. [PMID] 35293380.
2022
Healthcare Fraud Data Mining Methods: A Look Back and Look Ahead.
Perspectives in health information management. 19(1) [PMID] 35440932.
2021
Are Health Literacy and Patient Activation Related to Health Outcomes in Breast Cancer Patients?
Health literacy research and practice. 5(3):e171-e178 [DOI] 10.3928/24748307-20210524-02. [PMID] 34260317.
2017
Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas.
Journal of the American Pharmacists Association : JAPhA. 57(3):375-381 [DOI] 10.1016/j.japh.2017.03.012. [PMID] 28506398.
2015
Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma.
Journal of managed care & specialty pharmacy. 21(12):1124-32 [DOI] 10.18553/jmcp.2015.21.12.1124. [PMID] 26679962.
2015
Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
Journal of managed care & specialty pharmacy. 21(5):401-7 [DOI] 10.18553/jmcp.2015.21.5.401. [PMID] 25943001.
2015
Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.
Journal of managed care & specialty pharmacy. 21(10):956-64 [DOI] 10.18553/jmcp.2015.21.10.956. [PMID] 26402394.
2015
Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 24(5):1223-33 [DOI] 10.1007/s11136-014-0842-1. [PMID] 25432884.
2015
Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations.
Journal of managed care & specialty pharmacy. 21(6):507-14 [DOI] 10.18553/jmcp.2015.21.6.507. [PMID] 26011552.
2014
Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Journal of managed care & specialty pharmacy. 20(8):862-76 [DOI] 10.18553/jmcp.2014.20.8.862. [PMID] 25062080.
2014
Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.
CNS drugs. 28(11):1047-58 [DOI] 10.1007/s40263-014-0191-1. [PMID] 25086640.
2014
Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
Journal of managed care & specialty pharmacy. 20(9):914-9 [DOI] 10.18553/jmcp.2014.20.9.914. [PMID] 25166290.
2014
Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
Journal of managed care & specialty pharmacy. 20(7):657-67 [DOI] 10.18553/jmcp.2014.20.7.657. [PMID] 24967519.
2014
Trends and issues in oncology costs.
Expert review of pharmacoeconomics & outcomes research. 14(1):35-44 [DOI] 10.1586/14737167.2014.864561. [PMID] 24328809.
2013
Estimates of charges associated with emergency department and hospital inpatient care for opioid abuse-related events.
Journal of pain & palliative care pharmacotherapy. 27(3):206-13 [DOI] 10.3109/15360288.2013.803511. [PMID] 23879214.
2013
Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients.
Journal of managed care pharmacy : JMCP. 19(6):468-77 [DOI] 10.18553/jmcp.2013.19.6.468. [PMID] 23806061.
2013
Pharmacoeconomics education in US colleges and schools of pharmacy.
American journal of pharmaceutical education. 77(7) [DOI] 10.5688/ajpe777145. [PMID] 24052648.
2013
The authors’ reply to Gow et al.: “the state of health economic research in South Africa”.
PharmacoEconomics. 31(3):255-6 [DOI] 10.1007/s40273-013-0027-8. [PMID] 23430608.
2012
A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Clinical therapeutics. 34(3):605-13 [DOI] 10.1016/j.clinthera.2012.02.007. [PMID] 22386828.
2012
Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
Clinical therapeutics. 34(3):712-9 [DOI] 10.1016/j.clinthera.2012.01.028. [PMID] 22381712.
2012
Assessing the quality of pharmacoeconomic studies in India: a systematic review.
PharmacoEconomics. 30(9):749-62 [DOI] 10.2165/11590140-000000000-00000. [PMID] 22720697.
2012
Cost-effectiveness of expanded newborn screening in Texas.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 15(5):613-21 [DOI] 10.1016/j.jval.2012.02.007. [PMID] 22867769.
2012
Effect of social influences on pharmacists’ intention to report adverse drug events.
Journal of the American Pharmacists Association : JAPhA. 52(5):622-9 [PMID] 23023842.
2012
Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis.
The Annals of pharmacotherapy. 46(11):1453-69 [DOI] 10.1345/aph.1R041. [PMID] 23136353.
2012
Evaluation of health care costs and utilization patterns for patients with gout.
Clinical therapeutics. 34(3):640-52 [DOI] 10.1016/j.clinthera.2012.01.020. [PMID] 22381710.
2012
Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
Arthritis care & research. 64(9):1423-9 [DOI] 10.1002/acr.21696. [PMID] 22508663.
2012
Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility.
Schizophrenia research. 137(1-3):137-40 [DOI] 10.1016/j.schres.2012.01.043. [PMID] 22364675.
2012
Pharmacist reporting of serious adverse drug events to the Food and Drug Administration.
Journal of the American Pharmacists Association : JAPhA. 52(5):e109-12 [PMID] 23023857.
2012
Review of survey articles regarding medication therapy management (MTM) services/programs in the United States.
Journal of pharmacy practice. 25(4):457-70 [PMID] 22544620.
2012
The need for more evidence-based studies to justify the economic value for the provision of medication therapy management and other clinical pharmacy services.
Clinical therapeutics. 34(11):2196-9 [DOI] 10.1016/j.clinthera.2012.10.002. [PMID] 23149006.
2012
The state of health economic research in South Africa: a systematic review.
PharmacoEconomics. 30(10):925-40 [DOI] 10.2165/11589450-000000000-00000. [PMID] 22809450.
2012
Use of antidepressant agents and the risk of type 2 diabetes.
European journal of clinical pharmacology. 68(9):1295-302 [DOI] 10.1007/s00228-011-1168-3. [PMID] 22120432.
2012
Use of antidepressants and the risk of type 2 diabetes mellitus: a nested case-control study.
International journal of clinical pharmacy. 34(3):432-8 [DOI] 10.1007/s11096-012-9608-4. [PMID] 22249783.
2011
Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 14(8):1002-9 [DOI] 10.1016/j.jval.2011.05.043. [PMID] 22152168.
2011
Examination of pharmacists’ intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
Research in social & administrative pharmacy : RSAP. 7(4):369-82 [DOI] 10.1016/j.sapharm.2010.09.001. [PMID] 21272531.
2011
Influence of attitudes on pharmacists’ intention to report serious adverse drug events to the Food and Drug Administration.
British journal of clinical pharmacology. 72(1):143-52 [DOI] 10.1111/j.1365-2125.2011.03944.x. [PMID] 21332572.
2011
Retrospective evaluation of the impact of copayment increases for specialty medications on adherence and persistence in an integrated health maintenance organization system.
Clinical therapeutics. 33(5):598-607 [DOI] 10.1016/j.clinthera.2011.04.021. [PMID] 21665044.
2011
Texas pharmacists’ knowledge of reporting serious adverse drug events to the Food and Drug Administration.
Journal of the American Pharmacists Association : JAPhA. 51(3):397-403 [DOI] 10.1331/JAPhA.2011.10079. [PMID] 21555292.
2010
Switching of antiepileptic drug formulations.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 15(2):64-5 [PMID] 22477795.
2010
The need for oral antidiabetic treatment adherence studies in the pediatric population.
Clinical therapeutics. 32(7):1306-7 [DOI] 10.1016/j.clinthera.2010.07.009. [PMID] 20678678.
2010
The state of health economic evaluation research in Nigeria: a systematic review.
PharmacoEconomics. 28(7):539-53 [DOI] 10.2165/11536170-000000000-00000. [PMID] 20550221.
2009
Development of the burden of prior authorization of psychotherapeutics (BoPAP) scale to assess the effects of prior authorization among Texas Medicaid providers.
Administration and policy in mental health. 36(4):278-87 [DOI] 10.1007/s10488-009-0220-4. [PMID] 19350379.
2009
The need for validation studies of comorbidity adjustment instruments.
Clinical therapeutics. 31(7):1578-80 [DOI] 10.1016/j.clinthera.2009.07.013. [PMID] 19695407.
2008
Analysis of predictive value of four risk models in Medicaid recipients with chronic obstructive pulmonary disease in Texas.
Clinical therapeutics. 30 Spec No:1051-7 [DOI] 10.1016/j.clinthera.2008.06.001. [PMID] 18640479.
2008
Antipsychotic medication utilization trends among Texas veterans: 1997-2002.
The Annals of pharmacotherapy. 42(9):1229-38 [DOI] 10.1345/aph.1L155. [PMID] 18682544.
2008
Effects of a psychotherapeutic drug prior authorization (PA) requirement on patients and providers: a providers’ perspective.
Administration and policy in mental health. 35(3):181-8 [PMID] 18064560.
2008
Pharmacoeconomic education in US colleges and schools of pharmacy: an update.
American journal of pharmaceutical education. 72(3) [PMID] 18698384.
2007
Influences of attitudes on family physicians’ willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain.
Clinical therapeutics. 29 Suppl:2589-602 [DOI] 10.1016/j.clinthera.2007.12.007. [PMID] 18164924.
2007
Pharmacoepidemiology education in US colleges and schools of pharmacy.
American journal of pharmaceutical education. 71(4) [PMID] 17786268.
2007
The need for pharmacoeconomic studies of pharmacy services.
Clinical therapeutics. 29(7):1488-90 [PMID] 17825700.
2006
Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program.
Medical care. 44(1):87-90 [PMID] 16365617.
2006
Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
Drug safety. 29(7):621-32 [PMID] 16808554.
2006
The $64,000 question–what is a quality-adjusted life-year worth?
Clinical therapeutics. 28(7):1042-3 [PMID] 16990082.
2005
A comparison of the risk of hospitalizations due to chronicobstructive pulmonary disease in medicaid patients with various medication regimens, including ipratropium, inhaled corticosteroids, salmeterol, or their combination.
Clinical therapeutics. 27(3):346-54 [PMID] 15878389.
2005
A descriptive analysis of asthma-related medical services and prescription utilization among recipients in a Medicaid program.
The Journal of asthma : official journal of the Association for the Care of Asthma. 42(6):447-53 [PMID] 16293539.
2005
Trends in the use of typical and atypical antipsychotics in children and adolescents.
Journal of the American Academy of Child and Adolescent Psychiatry. 44(6):548-56 [PMID] 15908837.
2004
Education in pharmacoeconomics: an international multidisciplinary view.
PharmacoEconomics. 22(3):139-47 [PMID] 14871162.
2004
Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine.
Psychiatric services (Washington, D.C.). 55(2):151-6 [PMID] 14762239.
2004
Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 92(1):40-6 [PMID] 14756463.
2003
Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia.
The Journal of clinical psychiatry. 64(6):635-9 [PMID] 12823076.
2003
Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.
PharmacoEconomics. 21(10):683-97 [PMID] 12828491.
2003
Role of ethnicity in predicting antipsychotic medication adherence.
The Annals of pharmacotherapy. 37(5):625-30 [PMID] 12708934.
2002
Cost impact of botulinum toxin use in Medicaid-enrolled children with cerebral palsy.
Journal of the Southern Orthopaedic Association. 11(2):71-9 [PMID] 12741586.
2001
Dealing with skewed data: an example using asthma-related costs of medicaid clients.
Clinical therapeutics. 23(3):481-98 [PMID] 11318082.
2000
Satisfaction with a computerized practitioner order-entry system at two military health care facilities.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 57(23):2188-95 [PMID] 11127698.
1999
A comparison of antihypertensive medication utilization before and after guideline changes using the Department of Defense Prescription Database.
The Annals of pharmacotherapy. 33(5):548-53 [PMID] 10369615.
1999
Economic analysis of carboplatin versus cisplatin in lung and ovarian cancer.
PharmacoEconomics. 16(1):43-57 [PMID] 10539121.
1999
Fax technology for collecting outcomes data in a computer database.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 56(24):2540-2 [PMID] 10613373.
1999
Meta-analyses of the effectiveness of erythropoietin for end-stage renal disease and cancer.
Clinical therapeutics. 21(9):1443-55; discussion 1427 [PMID] 10509843.
1997
Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
Clinical therapeutics. 19(6):1433-45; discussion 1424 [PMID] 9444451.
1996
Benefits of certification for pharmacy specialists.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). NS36(2):128-34 [PMID] 8742011.
1996
Evaluation of physician intervention letters.
Medical care. 34(8):760-6 [PMID] 8709658.
1995
Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications.
Clinical therapeutics. 17(4):786-90 [PMID] 8565041.
1995
Effect of an automated, nursing unit-based drug-dispensing device on medication errors.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 52(17):1875-9 [PMID] 8528848.
1995
Effects of Medicaid drug utilization review intervention letters.
Clinical therapeutics. 17(3):525-33; discussion 516 [PMID] 7585856.
1995
Promotion of the appropriate use of outpatient drug therapy in the Texas Medicaid Program through retrospective drug use review.
Pharmacy practice management quarterly. 15(2):57-64 [PMID] 10143599.
1994
Documenting the value of pharmacist interventions.
American pharmacy. NS34(5):50-4 [PMID] 8037120.
1993
Consumers’ evaluation of value-added pharmacy services.
American pharmacy. NS33(3):48-56 [PMID] 8475848.
1993
Staff pharmacists’ opinions about performance appraisals.
American journal of hospital pharmacy. 50(6):1181-5 [PMID] 8517458.
1993
Use of clozapine in Texas state mental health facilities.
American journal of hospital pharmacy. 50(8):1663-6 [PMID] 8368220.
1992
Survey of formulary system policies and procedures.
American journal of hospital pharmacy. 49(1):100-3 [PMID] 1570847.
1990
Comparison of women pharmacy and nursing students.
American pharmacy. NS30(6):49-53 [PMID] 2368669.
1989
Evaluation of mobile cart decentralization.
Hospital pharmacy. 24(5):375-6, 378 [PMID] 10293288.
1988
Brief review of the literature on decentralized drug distribution in hospitals.
American journal of hospital pharmacy. 45(3):639-41 [PMID] 3285676.
1988
Pharmacists’ satisfaction with drug product selection legislation.
American pharmacy. NS28(10):27-32 [PMID] 3195462.
1987
Multidimensional work sampling to evaluate the effects of computerization in an outpatient pharmacy.
American journal of hospital pharmacy. 44(9):2060-7 [PMID] 3674044.
1986
Work measurement in pharmacy research.
American journal of hospital pharmacy. 43(10):2445-52 [PMID] 3538862.

Contact Details

Phones:
Business:
(352) 273-6268
Emails:
Business:
krascati@ufl.edu
Addresses:
Business Mailing:
PO Box 100496
GAINESVILLE FL 32610
Business Street:
1225 CENTER DR
GAINESVILLE FL 32610